2020
DOI: 10.1111/ajt.15784
|View full text |Cite
|
Sign up to set email alerts
|

Obesity, transplantation, and bariatric surgery: An evolving solution for a growing epidemic

Abstract: Obesity is a worldwide epidemic. In 2005, 25% of the world population was overweight (as defined by body mass index [BMI] 25-29.9 kg/m 2) and 10% was obese (BMI > 30 kg/m 2). 1 By 2030, the prevalence is projected to reach 38% overweight and 20% obese. In the United States, the rates of obesity in 2014 were 35% of men and 40% of women. 2 The health-related ramifications of obesity have been well documented, including but not limited to cardiovascular disease, diabetes mellitus (DM), and cancer. 3-5 In patients… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
44
0
2

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 58 publications
(46 citation statements)
references
References 121 publications
0
44
0
2
Order By: Relevance
“…Therefore, future studies concerning the effects of dietary advice and physical exercise on long-term survival are warranted. Furthermore, in selected patients, bariatric surgery, in particular sleeve gastrectomy, might be feasible and results in weight loss [51,52]. More research, however, is warranted to minimize risk of complications after bariatric surgery in OLT recipients.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, future studies concerning the effects of dietary advice and physical exercise on long-term survival are warranted. Furthermore, in selected patients, bariatric surgery, in particular sleeve gastrectomy, might be feasible and results in weight loss [51,52]. More research, however, is warranted to minimize risk of complications after bariatric surgery in OLT recipients.…”
Section: Discussionmentioning
confidence: 99%
“…It was proven that obesity was associated with a higher risk of delayed graft function, graft loss, and lower patient and graft survival, but interestingly, obese individuals without comorbidities can experience similar survival to nonobese recipients [30][31][32]. However, often due to obesityassociated comorbidities, their access to the transplant list and transplantation is inferior to non-obese [5,33]. Bariatric surgery is considered as a safe method of obesity treatment in that specific group of patients and feasible as a bridge therapy to kidney transplantation [6,[34][35][36].…”
Section: Discussionmentioning
confidence: 99%
“…This has resulted in a push to perform BS pre‐transplant, particularly in renal failure patients on the kidney wait‐list 20 . A White Paper from the American Society of Transplant Surgeons Obesity in Transplantation Taskforce published in 2020 endorses this approach 21 …”
Section: Discussionmentioning
confidence: 99%
“…While these studies are limited to case reports and case series, overall they demonstrate improved outcomes associated with resultant weight loss at the expense of increased surgical complexity of the latter procedure. A position paper from the American Society of Transplantation states sleeve gastrectomy as the preferred procedure in LTX, and calls for studies investigating simultaneous vs delayed bariatric surgery 21 . However, in the setting of remote history of pre‐transplant RYGB, as may be increasingly common in patients with ESLD listed for LTX given its association with increased risk of alcohol use disorder, 28 expected post transplant outcomes, particularly from an infectious risk standpoint, are relatively unknown.…”
Section: Discussionmentioning
confidence: 99%